Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
UCB, Inc.
ClinicalTrials.gov Identifier:
NCT00453583
First received: March 28, 2007
Last updated: December 13, 2013
Last verified: May 2012

March 28, 2007
December 13, 2013
March 2007
January 2008   (final data collection date for primary outcome measure)
Parent satisfaction on a 11-point scale [ Time Frame: duration of the study ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00453583 on ClinicalTrials.gov Archive Site
  • Physician satisfaction on an 11-point scale [ Time Frame: duration of the study ] [ Designated as safety issue: No ]
  • Efficacy, tolerability and global satisfaction [ Time Frame: duration of the study ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Primary Care

Allergies
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4581
January 2008
January 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children from 2-12 included
  • History of allergy
  • Used an Antihistamine within market authorization

Exclusion Criteria:

  • Child not yet treated for the presented allergy
Both
2 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00453583
A00420
Not Provided
UCB, Inc.
UCB, Inc.
Not Provided
Study Director: UCB Clinical Trial Call Center +1 877 822 9493 (UCB)
UCB, Inc.
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP